Anagenics Ltd has released a press release.
Response to ASX Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Cellmid to Refinance RnD Loan
- Cellmid receives $1.12M R&D Tax Credit
- Key Antibody Patent Granted in Europe
Later from Anagenics
- Midkine Strategy Update
- MK antibody publication and patent in bone healing
- USA Distribution Partnership for Cellmids Evolis
- CDY: Ikon Legal Action
- Transcript of Cellmid Investor Briefing Call
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics